Conformation and vasoreactivity of VIP in phospholipids: Effects of calmodulin

Peptides

Volumn 20, Issue 12, 1999, Pages 1497-1501

  Rubinstein, Israel ^a,b   Patel, Manisha ^a   Ikezaki, Hiroyuki ^a,b   Dagar, Sumeet ^a   Önyüksel, Hayat ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Arteriole; Circular dichroism; Hamster; Intravital microscopy; Microcirculation; PEG DSPE; Sterically stabilized micelles; Vasopressin

Indexed keywords

CALMODULIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; HAMSTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; VASODILATATION;

ANIMALS; ARTERIOLES; CALMODULIN; CHEEK; CIRCULAR DICHROISM; CRICETINAE; DRUG SYNERGISM; MALE; MESOCRICETUS; MICELLES; MICROCIRCULATION; PHOSPHOLIPIDS; PROTEIN CONFORMATION; VASOACTIVE INTESTINAL PEPTIDE; VASODILATION;

EID: 0033380276     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00161-8     Document Type: Article

References (25)

1. Andersson M., Carlquist M., Maletti M., Marie J-C. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity protein for VIP, shown to be identical to calmodulin. FEBS Lett. 318:1993;35-40.
2. Bodalia B, Önyüksel H, Rubinstein I. Surface-active properties of vasoactive intestinal peptide in vitro (Abstract). Am J Respir Crit Care Med 1999;159(part 2):A283.
3. Brizzolara A.L., Burnstock G. Endothelium-dependent and endothelium-independent vasodilatation on the hepatic artery of the rabbit. Br J Pharmacol. 103:1991;1206-1212.
4. Chiba K., Kurashima S., Mohri T. Interaction between lipids and bovine brain calmodulin lysophosphatidylcholine-induced conformational change . Life Sci. 47:1990;953-960.
5. Dawson R.A., Mac Neil S. Mitogenic role for extracellular calmodulin-like activity in normal human umbilical vein endothelial cells. Br J Haematol. 82:1992;151-160.
6. Duggan K.A., Ye V.Z. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels. Eur J Pharmacol. 358:1998;25-30.
7. Filizola M., Carteni-Farina M., Perez J.J. Conformational study of vasoactive intestinal peptide by computational methods. J Pept Res. 50:1997;55-64.
8. Gololobov G., Noda Y., Sherman S., Rubinstein I., Baranowska-Kortylewicz J., Paul S. Stabilization of vasoactive intestinal peptide by lipids. J Pharmacol Exp Ther. 285:1998;753-758.
9. Gulbenkian S., Opgaard O.S., Ekman R., Andrade N.C., Wharton J., Polak J.M., Queiroz e Melo J., Edvinsson L. Peptidergic innervation of human epicardial coronary arteries. Circ Res. 73:1993;579-588.
10. 2, a fragment with analgesic properties. Pept Res. 9:1996;327-331.
11. Houston D.S., Carson C.W., Esmon C.T. Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor (TNF) release and augment neutrophil elastase release. J Biol Chem. 272:1997;11778-11785.
12. Huang M., Rorstad O.P. VIP receptors in mesenteric and coronary arteries a radioligand binding study . Peptides. 8:1987;477-485.
13. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol. 253:1987;H1074-H1082.
14. Ikezaki H., Patel M., Önyüksel H., Akhter S.R., Gao X.-P., Rubinstein I. Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo. Am J Physiol. 276:1999;R1359-R1365.
15. Koch T.R., Michener S.R., Go V.L. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea. Gastroenterology. 100:1991;99-106.
16. Kummer W., Fischer A., Mundel P., Mayer B., Hoba B., Philippin B., Preissler U. Nitric oxide synthase in VIP-containing vasodilator nerve fibers in the Guinea-pig. NeuroReport. 3:1992;653-655.
17. Kwon G.S., Okano T. Polymeric micelles as new drug carriers. Adv Drug Del Rev. 21:1996;107-116.
18. Mac Neil S., Dawson R.A., Crocker G., Barton C.H., Hanford L., Metcalfe R., McGurk M., Munro D.S. Extracellular calmodulin and its association with epidermal growth factor in normal human body fluids. J Endocrinol. 118:1988;501-509.
19. Noda Y., Rodriguez-Sierra J., Liu J., Landers D., Mori A., Paul S. Partitioning of vasoactive intestinal polypeptide into lipid bilayers. Biochem Biophys Acta. 1191:1994;324-330.
20. O'Neil K.T., DeGrado W.F. How calmodulin binds its targets sequence independent recognition of amphiphilic α-helices . Trends Biochem Sci. 15:1990;59-64.
21. Önyüksel H., Ikezaki H., Patel M., Rubinstein I. A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo. Pharm Res. 16:1999;155-160.
22. Paul S., Ebadi M. Vasoactive intestinal peptide its interactions with calmodulin and catalytic antibodies . Neurochem Int. 23:1993;197-214.
23. Robinson R.M., Blakeney E.W. Jr, Mattice W.L. Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide. Biopolymers. 21:1982;1217-1228.
24. Stallwood D., Brugger C.H., Baggenstoss B.A., Stemmer P.M., Shiraga H., Landers D.F., Paul S. Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin. J Biol Chem. 267:1992;19617-19621.
25. Woodle M.C., Storm G., Newman M.S., Jekot J.J., Collins L.R., Martin F.J., Szoka F.C. Jr. Prolonged systemic delivery of peptide drugs by long-circulating liposomes illustration with vasopressin in the Brattleboro rat . Pharm Res. 9:1992;260-265.